{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T23:36:51Z","timestamp":1790465811659,"version":"4.1.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,11,20]],"date-time":"2018-11-20T00:00:00Z","timestamp":1542672000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12882-018-1132-x","type":"journal-article","created":{"date-parts":[[2018,11,20]],"date-time":"2018-11-20T07:28:52Z","timestamp":1542698932000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Minimal change nephrotic syndrome in patients infected with human immunodeficiency virus: a retrospective study of 8 cases"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6779-5368","authenticated-orcid":false,"given":"Romain","family":"ARRESTIER","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Pascale","family":"SATIE","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shao-yu","family":"ZHANG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuelle","family":"PLAISIER","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corinne","family":"ISNARD-BAGNIS","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"GATAULT","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quentin","family":"RAIMBOURG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"BUOB","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavia","family":"VOCILA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Elisabeth","family":"HENG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helene","family":"FRANCOIS","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anissa","family":"MOKTEFI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"CANAUD","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"MATIGNON","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"DEJUCQ-RAINSFORD","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"BROCHERIOU","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dil","family":"SAHALI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"AUDARD","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,11,20]]},"reference":[{"key":"1132_CR1","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1681\/ASN.2012070734","volume":"24","author":"J Hogan","year":"2013","unstructured":"Hogan J, Radhakrishnan J. The treatment of minimal change disease in adults. J Am Soc Nephrol JASN. 2013;24:702\u201311.","journal-title":"J Am Soc Nephrol JASN"},{"key":"1132_CR2","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1007\/s00281-013-0415-3","volume":"36","author":"D Sahali","year":"2014","unstructured":"Sahali D, Sendeyo K, Mangier M, Audard V, Zhang SY, Lang P, et al. Immunopathogenesis of idiopathic nephrotic syndrome with relapse. Semin Immunopathol. 2014;36:421\u20139.","journal-title":"Semin Immunopathol"},{"key":"1132_CR3","doi-asserted-by":"publisher","first-page":"3756","DOI":"10.1182\/blood-2009-11-251132","volume":"115","author":"V Audard","year":"2010","unstructured":"Audard V, Zhang S, Copie-Bergman C, Rucker-Martin C, Ory V, Candelier M, et al. Occurrence of minimal change nephrotic syndrome in classical Hodgkin lymphoma is closely related to the induction of c-mip in Hodgkin-reed Sternberg cells and podocytes. Blood. 2010;115:3756\u201362.","journal-title":"Blood"},{"key":"1132_CR4","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1097\/MD.0000000000000206","volume":"93","author":"T Kofman","year":"2014","unstructured":"Kofman T, Zhang S-Y, Copie-Bergman C, Moktefi A, Raimbourg Q, Francois H, et al. Minimal change nephrotic syndrome associated with non-Hodgkin lymphoid disorders: a retrospective study of 18 cases. Medicine (Baltimore). 2014;93:350\u20138.","journal-title":"Medicine (Baltimore)"},{"key":"1132_CR5","doi-asserted-by":"crossref","unstructured":"Karras A, de Montpreville V, Fakhouri F, Gr\u00fcnfeld J-P, Lesavre P, Groupe d\u2019Etudes des N\u00e9phropathies Associ\u00e9es aux Thymomes: renal and thymic pathology in thymoma-associated nephropathy: report of 21 cases and review of the literature. Nephrol Dial Transplant Off Publ Eur Dial Transpl Assoc - Eur Ren Assoc 2005;20:1075\u20131082.","DOI":"10.1093\/ndt\/gfh615"},{"key":"1132_CR6","first-page":"ra39","volume":"3","author":"S-Y Zhang","year":"2010","unstructured":"Zhang S-Y, Kamal M, Dahan K, Pawlak A, Ory V, Desvaux D, et al. C-mip impairs podocyte proximal signaling and induces heavy proteinuria. Sci Signal. 2010;3:ra39.","journal-title":"Sci Signal"},{"key":"1132_CR7","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1084\/jem.20030566","volume":"198","author":"P Grimbert","year":"2003","unstructured":"Grimbert P, Valanciute A, Audard V, Pawlak A, Le gouvelo S, Lang P, et al. Truncation of C-mip (Tc-mip), a new proximal signaling protein, induces c-maf Th2 transcription factor and cytoskeleton reorganization. J Exp Med. 2003;198:797\u2013807.","journal-title":"J Exp Med"},{"key":"1132_CR8","first-page":"1479","volume":"22","author":"M Aoyama","year":"2007","unstructured":"Aoyama M, Sugimoto T, Yokono T, Sakaguchi M, Deji N, Uzu T, et al. Minimal-change nephropathy and chronic hepatitis C infection: coincidental or associated? Nephrol Dial Transplant Off Publ Eur Dial Transpl Assoc - Eur Ren Assoc. 2007;22:1479\u201380.","journal-title":"Nephrol Dial Transplant Off Publ Eur Dial Transpl Assoc - Eur Ren Assoc"},{"key":"1132_CR9","doi-asserted-by":"publisher","first-page":"459","DOI":"10.3109\/0886022X.2014.1001711","volume":"37","author":"T-B Zhou","year":"2015","unstructured":"Zhou T-B, Jiang Z-P. Is there an association of hepatitis B virus infection with minimal change disease of nephrotic syndrome? A clinical observational report. Ren Fail. 2015;37:459\u201361.","journal-title":"Ren Fail"},{"key":"1132_CR10","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.1056\/NEJMra1508467","volume":"377","author":"SD Cohen","year":"2017","unstructured":"Cohen SD, Kopp JB, Kimmel PL. Kidney diseases associated with human immunodeficiency virus infection. N Engl J Med. 2017;377:2363\u201374.","journal-title":"N Engl J Med"},{"key":"1132_CR11","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1038\/nrneph.2015.9","volume":"11","author":"AZ Rosenberg","year":"2015","unstructured":"Rosenberg AZ, Naicker S, Winkler CA, Kopp JB. HIV-associated nephropathies: epidemiology, pathology, mechanisms and treatment. Nat Rev Nephrol. 2015;11:150\u201360.","journal-title":"Nat Rev Nephrol"},{"key":"1132_CR12","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/ki.2014.167","volume":"86","author":"MJ Ross","year":"2014","unstructured":"Ross MJ. Advances in the pathogenesis of HIV-associated kidney diseases. Kidney Int. 2014;86:266\u201374.","journal-title":"Kidney Int"},{"key":"1132_CR13","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1159\/000168461","volume":"12","author":"GS Lopes","year":"1992","unstructured":"Lopes GS, Marques LP, Rioja LS, Basilio-de-Oliveira CA, Oliveira AV, Nery AC, et al. Glomerular disease and human immunodeficiency virus infection in Brazil. Am J Nephrol. 1992;12:281\u20137.","journal-title":"Am J Nephrol"},{"key":"1132_CR14","unstructured":"Lescure F-X, Flateau C, Pacanowski J, Brocheriou I, Rondeau E, Girard P-M, et al. HIV-associated kidney glomerular diseases: changes with time and HAART. Nephrol Dial Transplant Off Publ Eur Dial Transpl Assoc - Eur Ren Assoc. 2012;27:2349\u201355."},{"key":"1132_CR15","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group: KDIGO clinical practice guideline for acute kidney injury. Kidney Int Supp. 2012;l2:1\u2013138."},{"key":"1132_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/kisup.2012.73","volume":"3","author":"Kidney Disease","year":"2013","unstructured":"Kidney Disease. Improving global outcomes (KDIGO) CKD work group: KDIGO clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl. 2013;3:1\u2013150.","journal-title":"Kidney Int Suppl"},{"key":"1132_CR17","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1681\/ASN.2013050564","volume":"25","author":"G Canaud","year":"2014","unstructured":"Canaud G, Dejucq-Rainsford N, Avettand-Feno\u00ebl V, Viard J-P, Anglicheau D, Bienaim\u00e9 F, et al. The kidney as a reservoir for HIV-1 after renal transplantation. J Am Soc Nephrol JASN. 2014;25:407\u201319.","journal-title":"J Am Soc Nephrol JASN"},{"key":"1132_CR18","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1038\/nrneph.2015.216","volume":"12","author":"E Nobakht","year":"2016","unstructured":"Nobakht E, Cohen SD, Rosenberg AZ, Kimmel PL. HIV-associated immune complex kidney disease. Nat Rev Nephrol. 2016;12:291\u2013300.","journal-title":"Nat Rev Nephrol"},{"key":"1132_CR19","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1681\/ASN.2011060562","volume":"23","author":"DM Fine","year":"2012","unstructured":"Fine DM, Wasser WG, Estrella MM, Atta MG, Kuperman M, Shemer R, et al. APOL1 risk variants predict histopathology and progression to ESRD in HIV-related kidney disease. J Am Soc Nephrol JASN. 2012;23:343\u201350.","journal-title":"J Am Soc Nephrol JASN"},{"key":"1132_CR20","doi-asserted-by":"publisher","first-page":"2882","DOI":"10.1681\/ASN.2014050469","volume":"26","author":"AN Kasembeli","year":"2015","unstructured":"Kasembeli AN, Duarte R, Ramsay M, Mosiane P, Dickens C, Dix-Peek T, et al. APOL1 risk variants are strongly associated with HIV-associated nephropathy in black south Africans. J Am Soc Nephrol JASN. 2015;26:2882\u201390.","journal-title":"J Am Soc Nephrol JASN"},{"key":"1132_CR21","doi-asserted-by":"publisher","unstructured":"Gribouval O, Boyer O, Knebelmann B, Karras A, Dantal J, Fourrage C, et al. APOL1 risk genotype in European steroid-resistant nephrotic syndrome and\/or focal segmental glomerulosclerosis patients of different African ancestries. Nephrol Dial Transplant Off Publ Eur Dial Transpl Assoc - Eur Ren Assoc. 2018. \n                    https:\/\/doi.org\/10.1093\/ndt\/gfy176\n                    \n                  .","DOI":"10.1093\/ndt\/gfy176"},{"key":"1132_CR22","doi-asserted-by":"publisher","first-page":"2325","DOI":"10.1007\/s00467-014-2860-1","volume":"29","author":"C Dossier","year":"2014","unstructured":"Dossier C, Sellier-Leclerc A-L, Rousseau A, Michel Y, Gautheret-Dejean A, Englender M, et al. Prevalence of herpesviruses at onset of idiopathic nephrotic syndrome. Pediatr Nephrol Berl Ger. 2014;29:2325\u201331.","journal-title":"Pediatr Nephrol Berl Ger"},{"key":"1132_CR23","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1038\/ki.2010.318","volume":"78","author":"LC Herlitz","year":"2010","unstructured":"Herlitz LC, Mohan S, Stokes MB, Radhakrishnan J, D\u2019Agati VD, Markowitz GS. Tenofovir nephrotoxicity: acute tubular necrosis with distinctive clinical, pathological, and mitochondrial abnormalities. Kidney Int. 2010;78:1171\u20137.","journal-title":"Kidney Int"},{"key":"1132_CR24","doi-asserted-by":"publisher","first-page":"445","DOI":"10.2215\/CJN.03531006","volume":"2","author":"M Waldman","year":"2007","unstructured":"Waldman M, Crew RJ, Valeri A, Busch J, Stokes B, Markowitz G, et al. Adult minimal-change disease: clinical characteristics, treatment, and outcomes. Clin J Am Soc Nephrol CJASN. 2007;2:445\u201353.","journal-title":"Clin J Am Soc Nephrol CJASN"},{"key":"1132_CR25","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1056\/NEJM200106283442604","volume":"344","author":"JA Winston","year":"2001","unstructured":"Winston JA, Bruggeman LA, Ross MD, Jacobson J, Ross L, D\u2019Agati VD, et al. Nephropathy and establishment of a renal reservoir of HIV type 1 during primary infection. N Engl J Med. 2001;344:1979\u201384.","journal-title":"N Engl J Med"},{"key":"1132_CR26","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1038\/ki.2012.426","volume":"83","author":"K Sendeyo","year":"2013","unstructured":"Sendeyo K, Audard V, Zhang S, Fan Q, Bouachi K, Ollero M, et al. Upregulation of c-mip is closely related to podocyte dysfunction in membranous nephropathy. Kidney Int. 2013;83:414\u201325.","journal-title":"Kidney Int"},{"key":"1132_CR27","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1016\/j.ajpath.2012.02.008","volume":"180","author":"V Ory","year":"2012","unstructured":"Ory V, Fan Q, Hamdaoui N, Zhang S, Desvaux D, Audard V, et al. C-mip down-regulates NF-\u03baB activity and promotes apoptosis in podocytes. Am J Pathol. 2012;180:2284\u201392.","journal-title":"Am J Pathol"},{"key":"1132_CR28","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1172\/JCI200421004","volume":"114","author":"JC He","year":"2004","unstructured":"He JC, Husain M, Sunamoto M, D\u2019Agati VD, Klotman ME, Iyengar R, et al. Nef stimulates proliferation of glomerular podocytes through activation of Src-dependent Stat3 and MAPK1,2 pathways. J Clin Invest. 2004;114:643\u201351.","journal-title":"J Clin Invest"},{"key":"1132_CR29","doi-asserted-by":"publisher","first-page":"2138","DOI":"10.1681\/ASN.2008080879","volume":"20","author":"X Feng","year":"2009","unstructured":"Feng X, Lu T-C, Chuang PY, Fang W, Ratnam K, Xiong H, et al. Reduction of Stat3 activity attenuates HIV-induced kidney injury. J Am Soc Nephrol JASN. 2009;20:2138\u201346.","journal-title":"J Am Soc Nephrol JASN"},{"key":"1132_CR30","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1053\/j.ajkd.2016.10.032","volume":"69","author":"RJ Maas","year":"2017","unstructured":"Maas RJ, Deegens JK, Beukhof JR, Reichert LJ, Ten Dam MA, Beutler JJ, et al. The clinical course of minimal change nephrotic syndrome with onset in adulthood or late adolescence: a case series. Am J Kidney Dis Off J Natl Kidney Found. 2017;69:637\u201346.","journal-title":"Am J Kidney Dis Off J Natl Kidney Found"},{"key":"1132_CR31","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1016\/S0140-6736(14)60541-9","volume":"384","author":"K Iijima","year":"2014","unstructured":"Iijima K, Sako M, Nozu K, Mori R, Tuchida N, Kamei K, et al. Rituximab for childhood-onset, complicated, frequently relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicentre, double-blind, randomised, placebo-controlled trial. Lancet Lond Engl. 2014;384:1273\u201381.","journal-title":"Lancet Lond Engl"},{"key":"1132_CR32","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1038\/ki.2012.444","volume":"83","author":"H Munyentwali","year":"2013","unstructured":"Munyentwali H, Bouachi K, Audard V, Remy P, Lang P, Mojaat R, et al. Rituximab is an efficient and safe treatment in adults with steroid-dependent minimal change disease. Kidney Int. 2013;83:511\u20136.","journal-title":"Kidney Int"},{"key":"1132_CR33","doi-asserted-by":"publisher","unstructured":"Boumediene A, Vachin P, Sendeyo K, Oniszczuk J, Zhang S-Y, Henique C, et al. NEPHRUTIX: a randomized, double-blind, placebo vs rituximab-controlled trial assessing T-cell subset changes in minimal change nephrotic syndrome. J Autoimmun. 2017. \n                    https:\/\/doi.org\/10.1016\/j.jaut.2017.10.006\n                    \n                  .","DOI":"10.1016\/j.jaut.2017.10.006"},{"key":"1132_CR34","doi-asserted-by":"publisher","first-page":"41","DOI":"10.2174\/156720112798376005","volume":"9","author":"E Reid","year":"2012","unstructured":"Reid E, Nooka A, Blackmon J, Lechowicz MJ. Clinical use of rituximab in patients with HIV related lymphoma and multicentric Castleman\u2019s disease. Curr Drug Deliv. 2012;9:41\u201351.","journal-title":"Curr Drug Deliv"},{"key":"1132_CR35","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.autrev.2017.04.007","volume":"16","author":"A Kronbichler","year":"2017","unstructured":"Kronbichler A, Windpessl M, Pieringer H, Jayne DRW. Rituximab for immunologic renal disease: what the nephrologist needs to know. Autoimmun Rev. 2017;16:633\u201343.","journal-title":"Autoimmun Rev"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-018-1132-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12882-018-1132-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-018-1132-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,19]],"date-time":"2019-11-19T19:26:38Z","timestamp":1574191598000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-018-1132-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,20]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1132"],"URL":"https:\/\/doi.org\/10.1186\/s12882-018-1132-x","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,20]]},"assertion":[{"value":"16 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was performed in accordance with the ethical standards of the Helsinki Declaration, and has been approved by our local institutional review board: IRB Mondor n\u00b000003835. All patients included in this study have given their written consent to perform if required a complementary investigation on their renal biopsy specimen and for the use of their personal data (data anonymization) after a declaration to the CNIL (French National Comission for Liberties and Informatic).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Patients have given their written consent to have their clinical and biological data published in an anonymized form.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"331"}}